8 Coupons
-
Special Offer
-
30% off
.
.
.comments
.eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.
. johns hopkins all children's hospital. [jim damaske |times]
.more stories from investigations
. .
.
.